A biopharmaceutical company focused on discovering and developing therapeutics to treat stress-related neuropsychiatric and mood disorders, with a lead compound PT00114—a synthetic form of an endogenous brain signaling peptide.
New York, NY, United States~1 employeesFounded Jan 2017Website
BiotechnologyNeuropsychiatric DisordersMood DisordersPeptide TherapeuticsDrug Development